GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (FRA:TKDA) » Definitions » 3-Year Dividend Growth Rate

Takeda Pharmaceutical Co (FRA:TKDA) 3-Year Dividend Growth Rate : 1.50% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co 3-Year Dividend Growth Rate?

Takeda Pharmaceutical Co's Dividends per Share for the three months ended in Sep. 2024 was €0.29.

The historical rank and industry rank for Takeda Pharmaceutical Co's 3-Year Dividend Growth Rate or its related term are showing as below:

FRA:TKDA' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 1.5   Med: 16.6   Max: 26.6
Current: 1.5

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Takeda Pharmaceutical Co was 26.60% per year. The lowest was 1.50% per year. And the median was 16.60% per year.

FRA:TKDA's 3-Year Dividend Growth Rate is ranked worse than
73.94% of 307 companies
in the Drug Manufacturers industry
Industry Median: 11.5 vs FRA:TKDA: 1.50

During the past 12 months, Takeda Pharmaceutical Co's average Dividends Per Share Growth Rate was 4.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 1.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 0.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Takeda Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Sep. 2024 was 1.63. As of today, Takeda Pharmaceutical Co's Dividend Yield % is 4.60%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Takeda Pharmaceutical Co Ltd is 1.06, which seems too high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Takeda Pharmaceutical Co's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's 3-Year Dividend Growth Rate falls into.



Takeda Pharmaceutical Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Takeda Pharmaceutical Co  (FRA:TKDA) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Takeda Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0.294/ 0.18
=1.63

During the past 13 years, the highest Dividend Payout Ratio of Takeda Pharmaceutical Co was 1.98. The lowest was 0.75. And the median was 1.20.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Takeda Pharmaceutical Co Ltd is 1.06, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Takeda Pharmaceutical Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.3260792024-09-302024-09-302024-12-12Cash Dividendsemi-annuallyUSD:EUR 0.901000
USD 0.2922142024-03-272024-03-282024-07-08Cash Dividendsemi-annuallyUSD:EUR 0.920000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Takeda Pharmaceutical Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.562634059/12.60
=4.47 %

Current Share Price is €12.60.
Takeda Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.562634059.

During the past 13 years, the highest Dividend Yield of Takeda Pharmaceutical Co was 6.17%. The lowest was 2.71%. And the median was 4.19%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takeda Pharmaceutical Co 3-Year Dividend Growth Rate Related Terms>


Takeda Pharmaceutical Co Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines